Abstract
The purpose of this study was to evaluate the efficacy of a low-dose cyclosporin therapy in psoriasis. In the multicentre study, carried out in Korea, 52 patients with moderate to severe psoriasis were treated with an initial dose of 2.5 mg/kg per day cyclosporin for 18 weeks. In 44 patients the dose was increased gradually up to 5 mg/kg per day according to the therapeutic response. Treatment success, defined as a reduction in PASI score by at least 66%, was achieved in 76.9% of patients. PASI scores reduced significantly from 20.0 to 5.4. Changes in systolic and diastolic blood pressure were not statistically significant. A 30% increase in serum creatinine in comparison with baseline was observed in five patients (9.6%) by the 18th week, but none of the patients showed an increase beyond the normal range. The overall assessments of efficacy and tolerability by both the investigators and the patients were mostly ‘good’ or ‘very good’. Our regimen of low-dose cyclosporin therapy (2.5 mg/kg per day initial...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
